Skip to content

Perimenopause and Menopause in Women With Spinal Cord Injury

Experiences of the Perimenopause and Menopause in Women With Spinal Cord Injury

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06709664
Enrollment
100
Registered
2024-11-29
Start date
2025-01-31
Completion date
2025-10-31
Last updated
2024-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause, Spinal Cord Injury

Brief summary

A lot of information is known about how the perimenopause and menopause affects able bodied women. However there is very little information about how these affects women with spinal cord injury. This questionnaire study aims to collect information from women with a spinal cord injury on their experiences of going through the perimenopause and/or the menopause.

Detailed description

There is widespread knowledge and information about the perimenopause and menopause, its symptoms and treatment; all of this is for people without spinal cord injury (women will be used to denote all people who can or have undergone the perimenopause and menopause). There is paucity of data about this condition in women with spinal cord injury. These women are living longer lives and should be supported to live a healthy life. Some studies have suggested that women with Spinal Cord Injury (wSCI) may undergo the perimenopause and menopause earlier than those without, however others have concluded that the age at the perimenopause and menopause is no different. wSCI may suffer less with vasomotor symptoms due to their ability to manage the symptoms of autonomic dysreflexia; however they may have more genito-urinary symptoms; also due to the need for self-catheterisation. Hormone Replacement Therapy (HRT) has many benefits including reduction in risk of fractures by slowing down the development of osteoporosis, thereby reducing fracture risk and morbidity. Reduced mobility also puts them at an increased risk of cardio-vascular disease. This study aims to gain information about these characteristics of the perimenopause and menopause in wSCI; the age at which they become menopausal and the most bothersome symptoms for them, treatment options offered to them as well as details of their spinal cord injury.

Interventions

BEHAVIORALQuestionnaire

Questionnaire study

Sponsors

James Cooper
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Patient is willing and able to give informed consent for participation in the study (or verbally confirm they wish to take part if someone completing on their behalf) * Who has undergone or currently experiencing the perimenopause or menopause * Aged 18 years old or older * Clinically diagnosed with a spinal cord Injury at least 3 months ago * Is either a) currently going through the perimenopause and menopause or b) has been through the perimenopause and menopause.

Exclusion criteria

* • Individuals who have yet to go through the perimenopause and/or menopause

Design outcomes

Primary

MeasureTime frameDescription
To collect more information on determine signs, symptoms and severity of these signs and symptoms of the perimenopause and menopause in women with spinal cord injury1 time point* Information on menstrual cycle * Frequency of autonomic dysreflexia * Typical signs of autonomic dysreflexia * Menopausal symptoms * Treatment for menopausal symptoms * Satisfaction of medication (for menopausal symptoms) * Satisfaction of support for the perimenopause and menopause

Secondary

MeasureTime frameDescription
To collect more information on establish how SCI affects the experience of the perimenopause and menopause1 time point* Patterns between level of injury and the perimenopause and menopause symptoms * Patterns between neurological level and the perimenopause and menopause symptoms

Contacts

Primary ContactSucheta Iyengar, BM
bht.research@nhs.net01296 831378
Backup ContactJames Cooper, BSc, MSc
james.cooper9@nhs.net07816020305

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026